<DOC>
	<DOCNO>NCT02904109</DOCNO>
	<brief_summary>The purpose study investigate effect eNOS activate agent triflusal episodic memory cognitive function participant chronic stress .</brief_summary>
	<brief_title>Influence Triflusal Cognitive Functions Subjects Under Chronic Stress</brief_title>
	<detailed_description>Randomised , placebo control , double blind , cross-over design Primary study outcome : Performance verbal memory task . Main secondary outcome : Performance work memory cognitive task influence mood , depression anxiety subjective memory impairment . Once daily oral administration 600 mg triflusal placebo mannitol 8 day cross-over trial washout period least 14 day two period . Each participant take triflusal well placebo</detailed_description>
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Triflusal</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<criteria>male female normotensive ( BP 90/60mmHg 140/90mmHg ) BMI 19 29 kg/m2 age 18 40 year experience chronic stress least 1 month ( TICS sum score subscale `` overextension work '' &gt; = 55 ) native fluent Germanspeaking able willing give write informed consent document signature comply requirement study protocol willing donate saliva sample DNAanalysis female : willing perform pregnancy test begin medication phase followup visit . Contraindications class drug study , e.g . know hypersensitivity allergy salicylate NSAIDs acute chronic psychiatric disorder ( e.g . major depression , psychosis , somatoform disorder , suicidal tendency ) except symptom chronic stress cognitive impairment detect DemTect concomitant acute chronic disease state ( e.g . renal failure , hepatic dysfunction , cardiovascular disease , acute infection etc . ) woman pregnant breast feed intention become pregnant course study lack safe contraception , define : female participant childbearing potential , use willing continue use medically reliable method contraception entire study duration , oral , injectable , implantable contraceptive , intrauterine contraceptive device , use method consider sufficiently reliable investigator individual case active peptic ulcer antecedent complicate peptic ulcer history peptic ulcer . Any active pathological bleeding history coagulation abnormality thyroid problem laboratory exclusion criterion : clinically significant value blood count ( incl . platelet ) , coagulation status blood chemistry outside reference range laboratory pathological ECG know suspect noncompliance , drug alcohol abuse inability follow procedure study , e.g . due language problem , psychological disorder , dementia , etc . participant participation another study investigational drug within 30 day precede</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>